| Year |
Citation |
Score |
| 2018 |
Miles LA, Baik N, Bai H, Makarenkova HP, Kiosses WB, Krajewski S, Castellino FJ, Valenzuela A, Varki NM, Mueller BM, Parmer RJ. The Plasminogen ReceptorPlg-Ris Essential for Mammary Lobuloalveolar Development and Lactation. Journal of Thrombosis and Haemostasis : Jth. PMID 29495105 DOI: 10.1111/Jth.13988 |
0.314 |
|
| 2017 |
Briens A, Bardou I, Lebas H, Miles LA, Parmer RJ, Vivien D, Docagne F. Astrocytes regulate the balance between plasminogen activation and plasmin clearance via cell-surface actin. Cell Discovery. 3: 17001. PMID 28417010 DOI: 10.1038/Celldisc.2017.1 |
0.302 |
|
| 2016 |
Miles LA, Baik N, Lighvani S, Khaldoyanidi S, Varki NM, Bai H, Mueller BM, Parmer RJ. Deficiency of Plasminogen Receptor, Plg-RKT, Causes Defects in Plasminogen Binding and Inflammatory Macrophage Recruitment in vivo. Journal of Thrombosis and Haemostasis : Jth. PMID 27714956 DOI: 10.1111/Jth.13532 |
0.337 |
|
| 2014 |
Miles LA, Lighvani S, Baik N, Parmer CM, Khaldoyanidi S, Mueller BM, Parmer RJ. New insights into the role of Plg-RKT in macrophage recruitment. International Review of Cell and Molecular Biology. 309: 259-302. PMID 24529725 DOI: 10.1016/B978-0-12-800255-1.00005-3 |
0.354 |
|
| 2013 |
Miles LA, Parmer RJ. Plasminogen receptors: the first quarter century. Seminars in Thrombosis and Hemostasis. 39: 329-37. PMID 23532575 DOI: 10.1055/S-0033-1334483 |
0.339 |
|
| 2012 |
Miles LA, Lighvani S, Baik N, Andronicos NM, Chen EI, Parmer CM, Khaldoyanidi S, Diggs JE, Kiosses WB, Kamps MP, Yates JR, Parmer RJ. The plasminogen receptor, Plg-R(KT), and macrophage function. Journal of Biomedicine & Biotechnology. 2012: 250464. PMID 23125524 DOI: 10.1155/2012/250464 |
0.361 |
|
| 2012 |
Bai H, Nangia S, Parmer RJ. The plasminogen activation system and the regulation of catecholaminergic function. Journal of Biomedicine & Biotechnology. 2012: 721657. PMID 23097598 DOI: 10.1155/2012/721657 |
0.375 |
|
| 2012 |
Félez J, Jardà M, Fà bregas P, Parmer RJ, Miles LA. Monoclonal antibodies against receptor-induced binding sites detect cell-bound plasminogen in blood. Blood. 120: 678-81. PMID 22649107 DOI: 10.1182/Blood-2012-02-410480 |
0.336 |
|
| 2011 |
Lighvani S, Baik N, Diggs JE, Khaldoyanidi S, Parmer RJ, Miles LA. Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT. Blood. 118: 5622-30. PMID 21940822 DOI: 10.1182/Blood-2011-03-344242 |
0.305 |
|
| 2011 |
Bai H, Baik N, Kiosses WB, Krajewski S, Miles LA, Parmer RJ. The novel plasminogen receptor, plasminogen receptor(KT) (Plg-R(KT)), regulates catecholamine release. The Journal of Biological Chemistry. 286: 33125-33. PMID 21795689 DOI: 10.1074/Jbc.M111.218693 |
0.357 |
|
| 2011 |
Han J, Baik N, Kim KH, Yang JM, Han GW, Gong Y, Jardà M, Castellino FJ, Felez J, Parmer RJ, Miles LA. Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen. Blood. 118: 1653-62. PMID 21680799 DOI: 10.1182/Blood-2010-11-316943 |
0.313 |
|
| 2011 |
Jiang Q, Gingles NA, Olivier MA, Miles LA, Parmer RJ. The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles. Blood. 117: 7155-63. PMID 21596853 DOI: 10.1182/Blood-2010-05-287672 |
0.356 |
|
| 2010 |
Andronicos NM, Chen EI, Baik N, Bai H, Parmer CM, Kiosses WB, Kamps MP, Yates JR, Parmer RJ, Miles LA. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation. Blood. 115: 1319-30. PMID 19897580 DOI: 10.1182/Blood-2008-11-188938 |
0.358 |
|
| 2009 |
Gutiérrez-Fernández A, Gingles NA, Bai H, Castellino FJ, Parmer RJ, Miles LA. Plasminogen enhances neuritogenesis on laminin-1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 12393-400. PMID 19812315 DOI: 10.1523/Jneurosci.3553-09.2009 |
0.341 |
|
| 2006 |
Miles LA, Andronicos NM, Baik N, Parmer RJ. Cell-surface actin binds plasminogen and modulates neurotransmitter release from catecholaminergic cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 13017-24. PMID 17167091 DOI: 10.1523/Jneurosci.2070-06.2006 |
0.38 |
|
| 2006 |
Miles L, Andronicos N, Baik N, Parmer R. ID: 363 MODULATION OF NEUROTRANSMITTER RELEASE FROM CATECHOLAMINERGIC CELLS BY THE BINDING OF PLASMINOGEN TO CELL SURFACE ACTIN FORMS Journal of Thrombosis and Haemostasis. 4: 145-145. DOI: 10.1111/J.1538-7836.2006.00363.X |
0.302 |
|
| 2005 |
Etzel JP, Rana BK, Wen G, Parmer RJ, Schork NJ, O'Connor DT, Insel PA. Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response. Hypertension. 45: 1207-13. PMID 15920038 DOI: 10.1161/01.Hyp.0000166721.42734.49 |
0.335 |
|
| 2005 |
ETZEL J, RANA B, WEN G, PARMER R, SCHORK N, OCONNOR D, INSEL P. Genetic variation in the human ?2B-ADRENERGIC receptor gene: Haplotypes and yohimbine response Clinical Pharmacology & Therapeutics. 77: P7-P7. DOI: 10.1016/J.Clpt.2004.11.028 |
0.315 |
|
| 2003 |
Lee JC, Taylor CV, Gaucher SP, Toneff T, Taupenot L, Yasothornsrikul S, Mahata SK, Sei C, Parmer RJ, Neveu JM, Lane WS, Gibson BW, O'Connor DT, Hook VY. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells. Biochemistry. 42: 6938-46. PMID 12795588 DOI: 10.1021/Bi0300433 |
0.308 |
|
| 2003 |
Chitbangonsyn SW, Mahboubi P, Walker D, Rana BK, Diggle KL, Timberlake DS, Parmer RJ, O'Connor DT. Physical mapping of autonomic/sympathetic candidate genetic loci for hypertension in the human genome: a somatic cell radiation hybrid library approach. Journal of Human Hypertension. 17: 319-24. PMID 12756404 DOI: 10.1038/Sj.Jhh.1001550 |
0.629 |
|
| 2003 |
Wong CM, O'Connor DT, Martinez JA, Kailasam MT, Parmer RJ. Diminished renal kallikrein responses to mineralocorticoid stimulation in African Americans: determinants of an intermediate phenotype for hypertension. American Journal of Hypertension. 16: 281-9. PMID 12670744 DOI: 10.1016/S0895-7061(03)00002-5 |
0.303 |
|
| 2002 |
O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ. The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension. Annals of the New York Academy of Sciences. 971: 533-5. PMID 12438176 DOI: 10.1111/J.1749-6632.2002.Tb04520.X |
0.319 |
|
| 2002 |
Parmer RJ, Zinder O. Catecholaminergic pathways, chromaffin cells, and human disease. Annals of the New York Academy of Sciences. 971: 497-505. PMID 12438170 DOI: 10.1111/J.1749-6632.2002.Tb04514.X |
0.318 |
|
| 2002 |
Jiang Q, Yasothornsrikul S, Taupenot L, Miles LA, Parmer RJ. The local chromaffin cell plasminogen/plasmin system and the regulation of catecholamine secretion. Annals of the New York Academy of Sciences. 971: 445-9. PMID 12438162 DOI: 10.1111/J.1749-6632.2002.Tb04506.X |
0.369 |
|
| 2002 |
Taupenot L, Harper KL, Mahapatra NR, Parmer RJ, Mahata SK, O'Connor DT. Identification of a novel sorting determinant for the regulated pathway in the secretory protein chromogranin A. Journal of Cell Science. 115: 4827-41. PMID 12432071 DOI: 10.1242/Jcs.00140 |
0.311 |
|
| 2002 |
Bannach FG, Gutierrez A, Fowler BJ, Bugge TH, Degen JL, Parmer RJ, Miles LA. Localization of regulatory elements mediating constitutive and cytokine-stimulated plasminogen gene expression. The Journal of Biological Chemistry. 277: 38579-88. PMID 12149246 DOI: 10.1074/Jbc.M202509200 |
0.332 |
|
| 2002 |
O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. Journal of Hypertension. 20: 1335-45. PMID 12131530 DOI: 10.1097/00004872-200207000-00020 |
0.348 |
|
| 2001 |
Jiang Q, Taupenot L, Mahata SK, Mahata M, O'Connor DT, Miles LA, Parmer RJ. Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. The Journal of Biological Chemistry. 276: 25022-9. PMID 11342539 DOI: 10.1074/Jbc.M101545200 |
0.364 |
|
| 2001 |
Timberlake DS, O'Connor DT, Parmer RJ. Molecular genetics of essential hypertension: recent results and emerging strategies. Current Opinion in Nephrology and Hypertension. 10: 71-9. PMID 11195056 DOI: 10.1097/00041552-200101000-00012 |
0.636 |
|
| 2000 |
Kailasam MT, Parmer RJ, Tyrell EA, Henry RR, O'Connor DT. Circulating amylin in human essential hypertension: Heritability and early increase in individuals at genetic risk Journal of Hypertension. 18: 1611-1620. PMID 11081774 DOI: 10.1097/00004872-200018110-00012 |
0.331 |
|
| 2000 |
Parmer RJ, Mahata M, Gong Y, Mahata SK, Jiang Q, O'Connor DT, Xi XP, Miles LA. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion. The Journal of Clinical Investigation. 106: 907-15. PMID 11018079 DOI: 10.1172/Jci7394 |
0.366 |
|
| 2000 |
O'Connor DT, Insel PA, Ziegler MG, Hook VY, Smith DW, Hamilton BA, Taylor PW, Parmer RJ. Heredity and the autonomic nervous system in human hypertension. Current Hypertension Reports. 2: 16-22. PMID 10982526 DOI: 10.1007/S11906-000-0053-8 |
0.336 |
|
| 2000 |
Herrmann V, Büscher R, Go MM, Ring KM, Hofer JK, Kailasam MT, O'Connor DT, Parmer RJ, Insel PA. Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans. American Journal of Hypertension. 13: 1021-6. PMID 10981553 DOI: 10.1016/S0895-7061(00)01188-2 |
0.318 |
|
| 2000 |
Taylor CV, Taupenot L, Mahata SK, Mahata M, Wu H, Yasothornsrikul S, Toneff T, Caporale C, Jiang Q, Parmer RJ, Hook VY, O'Connor DT. Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules. The Journal of Biological Chemistry. 275: 22905-15. PMID 10781584 DOI: 10.1074/Jbc.M001232200 |
0.313 |
|
| 1999 |
O'Connor DT, Takiyyuddin MA, Printz MP, Dinh TQ, Barbosa JA, Rozansky DJ, Mahata SK, Wu H, Kennedy BP, Ziegler MG, Wright FA, Schlager G, Parmer RJ. Catecholamine storage vesicle protein expression in genetic hypertension. Blood Pressure. 8: 285-95. PMID 10803489 DOI: 10.1080/080370599439508 |
0.339 |
|
| 1998 |
Parmer RJ, Miles LA. Targeting of tissue plasminogen activator to the regulated pathway of secretion. Trends in Cardiovascular Medicine. 8: 306-12. PMID 14987555 DOI: 10.1016/S1050-1738(98)00025-5 |
0.345 |
|
| 1998 |
Mahata M, Mahata SK, Parmer RJ, O'Connor DT. Proadrenomedullin N-terminal 20 peptide: Minimal active region to regulate nicotinic receptors Hypertension. 32: 907-916. PMID 9822452 DOI: 10.1161/01.Hyp.32.5.907 |
0.305 |
|
| 1998 |
Mahata SK, Mahata M, Yoo SH, Taupenot L, Wu H, Aroda VR, Livsey CV, Taulane JP, Goodman M, Parmer RJ, O'Connor DT. A novel, catecholamine release-inhibitory peptide from chromogranin A: autocrine control of nicotinic cholinergic-stimulated exocytosis Advances in Pharmacology (San Diego, Calif.). 42: 260-264. PMID 9327894 DOI: 10.1016/S1054-3589(08)60743-7 |
0.311 |
|
| 1997 |
Tang K, Wu H, Mahata SK, Mahata M, Gill BM, Parmer RJ, O'Connor DT. Stimulus coupling to transcription versus secretion in pheochromocytoma cells. Convergent and divergent signal transduction pathways and the crucial roles for route of cytosolic calcium entry and protein kinase C Journal of Clinical Investigation. 100: 1180-1192. PMID 9276735 DOI: 10.1172/Jci119630 |
0.306 |
|
| 1997 |
Jenkins GR, Seiffert D, Parmer RJ, Miles LA. Regulation of plasminogen gene expression by interleukin-6. Blood. 89: 2394-403. PMID 9116283 DOI: 10.1182/Blood.V89.7.2394 |
0.331 |
|
| 1997 |
Parmer RJ, Mahata M, Mahata S, Sebald MT, O'Connor DT, Miles LA. Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA. The Journal of Biological Chemistry. 272: 1976-82. PMID 8999889 DOI: 10.1074/Jbc.272.3.1976 |
0.319 |
|
| 1996 |
Kailasam MT, O'Connor DT, Parmer RJ. Hereditary intermediate phenotypes in African American hypertension Ethnicity and Health. 1: 117-128. PMID 9395555 DOI: 10.1080/13557858.1996.9961778 |
0.346 |
|
| 1995 |
Wu H, Mahata SK, Mahata M, Webster NJG, Parmer RJ, O'Connor DT. A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A Journal of Clinical Investigation. 96: 568-578. PMID 7615829 DOI: 10.1172/Jci118069 |
0.351 |
|
| 1995 |
Takiyyuddin MA, Parmer RJ, Kailasam MT, Cervenka JH, Kennedy B, Ziegler MG, Lin MC, Li J, Grim CE, Wright FA. Chromogranin A in human hypertension. Influence of heredity. Hypertension. 26: 213-20. PMID 7607727 DOI: 10.1161/01.Hyp.26.1.213 |
0.363 |
|
| 1995 |
Kailasam MT, Parmer RJ, Cervenka JH, Wu RA, Ziegler MG, Kennedy BP, Adegbile IA, O'Connor DT. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension. 26: 143-9. PMID 7607717 DOI: 10.1161/01.Hyp.26.1.143 |
0.305 |
|
| 1994 |
Rozansky DJ, Wu H, Tang K, Parmer RJ, O'Connor DT. Glucocorticoid activation of chromogranin A gene expression: Identification and characterization of a novel glucocorticoid response element Journal of Clinical Investigation. 94: 2357-2368. PMID 7989592 DOI: 10.1172/Jci117601 |
0.359 |
|
| 1994 |
Takiyyuddin MA, Brown MR, Dinh TQ, Cervenka JH, Braun SD, Parmer RJ, Kennedy B, O'Connor DT. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release. Journal of Autonomic Pharmacology. 14: 187-200. PMID 7929473 DOI: 10.1111/J.1474-8673.1994.Tb00601.X |
0.307 |
|
| 1994 |
Kailasam MT, OʼConnor DT, Parmer RJ. The regulation and role of catecholamines in hypertension and pheochromocytoma Current Opinion in Endocrinology and Diabetes. 1: 135-142. DOI: 10.1097/00060793-199400010-00025 |
0.31 |
|
| 1993 |
Takiyyuddin MA, De Nicola L, Gabbai FB, Dinh TQ, Kennedy B, Ziegler MG, Sabban EL, Parmer RJ, O'Connor DT. Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension. Hypertension. 21: 674-9. PMID 8491501 DOI: 10.1161/01.Hyp.21.5.674 |
0.306 |
|
| 1993 |
Parmer RJ, Miles LA, Xi XP, Gill BM, Wu HJ, O'Connor DT. Processing of chromaffin granule proteins: a profusion of proteases? Neurochemistry International. 22: 361-7. PMID 8457772 DOI: 10.1016/0197-0186(93)90018-Z |
0.306 |
|
| 1993 |
Parmer RJ, Xi XP, Wu HJ, Helmen LJ, Petz LN. Secretory protein traffic: Chromogranin a contains a dominant targeting signal for the regulated pathway Journal of Clinical Investigation. 92: 1042-1054. PMID 8394383 DOI: 10.1172/Jci116609 |
0.339 |
|
| 1991 |
Takiyyuddin MA, Baron AD, Cervenka JH, Barbosa JA, Neumann HP, Parmer RJ, Sullivan PA, O'Connor DT. Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies. The Journal of Clinical Endocrinology and Metabolism. 72: 616-22. PMID 1671783 DOI: 10.1210/Jcem-72-3-616 |
0.307 |
|
| 1990 |
Takiyyuddin MA, Cervenka JH, Hsiao RJ, Barbosa JA, Parmer RJ, O'Connor DT. Chromogranin A. Storage and release in hypertension. Hypertension. 15: 237-46. PMID 2406199 DOI: 10.1161/01.Hyp.15.3.237 |
0.327 |
|
| 1990 |
Takiyyuddin MA, Cervenka JH, Sullivan PA, Pandian MR, Parmer RJ, Barbosa JA, O'Connor DT. Is physiologic sympathoadrenal catecholamine release exocytotic in humans? Circulation. 81: 185-95. PMID 2404624 DOI: 10.1161/01.Cir.81.1.185 |
0.319 |
|
| 1990 |
Parmer RJ, Cervenka JH, Stone RA, O'Connor DT. Autonomic function in hypertension. Are there racial differences? Circulation. 81: 1305-11. PMID 1969334 DOI: 10.1161/01.Cir.81.4.1305 |
0.327 |
|
| 1989 |
Parmer RJ, Koop AH, Handa MT, O'Connor DT. Molecular cloning of chromogranin A from rat pheochromocytoma cells Hypertension. 14: 435-444. PMID 2793216 DOI: 10.1161/01.Hyp.14.4.435 |
0.312 |
|
| 1985 |
Parmer RJ, Mosley C, O'Connor DT. Enkephalins in pheochromocytoma: studies in a rat model. Clinical and Experimental Hypertension. Part a, Theory and Practice. 7: 483-512. PMID 2408793 DOI: 10.3109/10641968509077208 |
0.302 |
|
| Show low-probability matches. |